SCHEMBL5162047

SCHEMBL5162047

CC(O)(F)C(F)(F)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
TSHR P16473 3/20 0.50
ACLY P53396 2/20 0.44
THRB P10828 1/20 0.43
HMGCR P04035 1/20 0.35
CHRM1 P11229 1/20 0.35
TBXA2R P21731 1/20 0.35
ADRA1A P35348 1/20 0.35
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
HIF1A Q16665 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TET2 Q6N021 2/20 0.32
PDK1 Q15118 2/20 0.30
PDK2 Q15119 2/20 0.30
PDK3 Q15120 2/20 0.30
PDK4 Q16654 2/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5162053 1.00 ALDH1A1 (0.50) ALDH1A1TSHRACLYTHRBHMGCR
SCHEMBL891464 0.81 ALDH1A1 (0.50) ALDH1A1TSHRACLYTHRBHMGCR
SCHEMBL1907923 0.78 THRB (0.46) ALDH1A1TSHRACLYTHRBHMGCR
SCHEMBL14365547 0.78 THRB (0.46) ALDH1A1TSHRACLYTHRBHMGCR
SCHEMBL8395910 0.78 THRB (0.46) ALDH1A1TSHRACLYTHRBHMGCR
SCHEMBL26348120 0.76
SCHEMBL508043 0.75 THRB (0.56) ALDH1A1TSHRACLYTHRBL3MBTL1
SCHEMBL10897817 0.75 THRB (0.43) ALDH1A1TSHRACLYTHRBCYP2D6
Trifluoroacetic Acid SCHEMBL2455122 0.73 ALDH1A1 (0.56) ALDH1A1TSHRACLYTHRBHMGCR
SCHEMBL5963798 0.73 THRB (0.42) ALDH1A1TSHRACLYTHRBCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054974-B1 METHOD FOR PRODUCING TRIFLUORO-3(R)-HYDROXYBUTYRIC ACID DERIVATIVES LONZA AG (CH) 2007-03-28 EP disclosed
US-6893861-B1 Method for producing trifluoro-3(r)-hydroxybutyric acid derivatives LONZA AG (CH) 2005-05-17 US disclosed
US-6893861-B1 Method for producing trifluoro-3(r)-hydroxybutyric acid derivatives LONZA AG (CH) 2005-05-17 US disclosed
US-6893861-B1 Method for producing trifluoro-3(r)-hydroxybutyric acid derivatives LONZA AG (CH) 2005-05-17 US disclosed
US-20030088095-A1 Reacting an optically active imine with a hemiacetal of a perfluoroalkylaldehyde or a hydrate; hydrolyzing the condensate under an acid condition. CENTRAL GLASS COMPANY, LIMITED 2003-05-08 US disclosed
EP-1054974-A1 METHOD FOR PRODUCING TRIFLUORO-3(R)-HYDROXYBUTYRIC ACID DERIVATIVES Lonza AG (CH) 2000-11-29 EP disclosed
WO-1999042590-A1 METHOD FOR PRODUCING TRIFLUORO-3(R)-HYDROXYBUTYRIC ACID DERIVATIVES LONZA AG (CH) 1999-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030088095-A1 Reacting an optically active imine with a hemiacetal of a perfluoroalkylaldehyde or a hydrate; hydrolyzing the condensate under an acid condition. ADH1C, ADH1A, HPD ALDH1A1 25/4885TSHR 1989/4885ACLY 3299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.